The Re-emergence and Transmission of Monkeypox Virus in Nigeria: the Role of One Health

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Jan 22

PMID 38249416

Authors

Seto C Ogunleye

Olalekan C Akinsulie

Abdullahi T Aborode

Mercy M Olorunshola

Damilola Gbore

Moyinoluwa Oladoye

Ridwan O Adesola

Joy O Gbadegoye

Boluwatife J Olatoye

Mariam A Lawal

Akeem B Bakare

Oluwabori Adekanye

Ezemba C Chinyere

Affiliations

Soon will be listed here.

Abstract

The Monkeypox virus, commonly abbreviated as mpox, is a viral zoonosis that is experiencing a resurgence in prevalence. It is endemic to regions of West and Central Africa that are characterized by dense forested areas. Various measures pertaining to animals, humans, and the environment have been recognized as potential factors and catalysts for the spread of the disease throughout the impacted regions of Africa. This study examines the various factors contributing to the transmission of the virus in Nigeria, with a particular focus on the animal-human and inter-human modes of transmission in rural communities and healthcare facilities. The One Health approach was emphasized as crucial in the prevention and management of this issue. Literature suggests that preventing repeated zoonotic introductions could potentially halt the transmission of the mpox virus from animal to human hosts, leading to a potential decrease in human infections.

Citing Articles

Clade Ib: a new emerging threat in the Mpox outbreak.

Srivastava S, Laxmi , Sharma K, Sridhar S, Talath S, Shareef J Front Pharmacol. 2025; 15:1504154.

PMID: 39749207 PMC: 11693458. DOI: 10.3389/fphar.2024.1504154.

Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses.

Gashema P, Musafiri T, Ndahimana F, Iradukunda H, Saramba E, Nyakatswau S Viruses. 2024; 16(10).

PMID: 39459912 PMC: 11512314. DOI: 10.3390/v16101578.

A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices.

Musuka G, Moyo E, Tungwarara N, Mhango M, Pierre G, Saramba E IJID Reg. 2024; 12:100402.

PMID: 39157420 PMC: 11326932. DOI: 10.1016/j.ijregi.2024.100402.

References

Reynolds M, Yorita K, Kuehnert M, Davidson W, Huhn G, Holman R . Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006; 194(6):773-80. DOI: 10.1086/505880. View

Nguyen P, Ajisegiri W, Costantino V, Chughtai A, MacIntyre C . Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020. Emerg Infect Dis. 2021; 27(4). PMC: 8007331. DOI: 10.3201/eid2704.203569. View

Rimoin A, Mulembakani P, Johnston S, Lloyd Smith J, Kisalu N, Kinkela T . Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A. 2010; 107(37):16262-7. PMC: 2941342. DOI: 10.1073/pnas.1005769107. View

Kugelman J, Johnston S, Mulembakani P, Kisalu N, Lee M, Koroleva G . Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis. 2014; 20(2):232-9. PMC: 3901482. DOI: 10.3201/eid2002.130118. View

Aborode A, Huang H, Wireko A, Mehta A, Kalmanovich J, Abdul-Rahman T . Approaching COVID-19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa. J Med Virol. 2022; 95(1):e28308. PMC: 9878081. DOI: 10.1002/jmv.28308. View

DAntonio F, Pagani G, Buca D, Khalil A . Monkeypox infection in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol MFM. 2022; 5(1):100747. PMC: 9555294. DOI: 10.1016/j.ajogmf.2022.100747. View

Breman J, Henderson D . Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism. N Engl J Med. 1998; 339(8):556-9. DOI: 10.1056/NEJM199808203390811. View

Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S . Reemergence of Human Monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018; 24(6):1149-1151. PMC: 6004876. DOI: 10.3201/eid2406.180017. View

Hraib M, Jouni S, Albitar M, Alaidi S, Alshehabi Z . The outbreak of monkeypox 2022: An overview. Ann Med Surg (Lond). 2022; 79:104069. PMC: 9289401. DOI: 10.1016/j.amsu.2022.104069. View

10.

Fuller T, Thomassen H, Mulembakani P, Johnston S, Lloyd-Smith J, Kisalu N . Using remote sensing to map the risk of human monkeypox virus in the Congo Basin. Ecohealth. 2010; 8(1):14-25. PMC: 3237841. DOI: 10.1007/s10393-010-0355-5. View

11.

Taub D, Ershler W, Janowski M, Artz A, Key M, McKelvey J . Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med. 2008; 121(12):1058-64. PMC: 2610468. DOI: 10.1016/j.amjmed.2008.08.019. View

12.

Chavda V, Vora L, Apostolopoulos V . Monkeypox: a new face of outbreak. Expert Rev Vaccines. 2022; 21(11):1537-1540. PMC: 9491104. DOI: 10.1080/14760584.2022.2113515. View

13.

Reynolds M, Carroll D, Karem K . Factors affecting the likelihood of monkeypox's emergence and spread in the post-smallpox era. Curr Opin Virol. 2012; 2(3):335-43. PMC: 9533834. DOI: 10.1016/j.coviro.2012.02.004. View

14.

Kalthan E, Tenguere J, Ndjapou S, Koyazengbe T, Mbomba J, Marada R . Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic. Med Mal Infect. 2018; 48(4):263-268. PMC: 9533891. DOI: 10.1016/j.medmal.2018.02.010. View

15.

Shafaati M, Zandi M, Choudhary O . Monkeypox virus crosstalk with HIV; where do we stand now?. Int J Surg. 2022; 105:106897. PMC: 9533877. DOI: 10.1016/j.ijsu.2022.106897. View

16.

Hammarlund E, Lewis M, Hansen S, Strelow L, Nelson J, Sexton G . Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003; 9(9):1131-7. DOI: 10.1038/nm917. View

17.

Kabuga A, El Zowalaty M . A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol. 2018; 91(4):533-540. DOI: 10.1002/jmv.25348. View

18.

Alakunle E, Moens U, Nchinda G, Okeke M . Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses. 2020; 12(11). PMC: 7694534. DOI: 10.3390/v12111257. View

19.

Patrono L, Pleh K, Samuni L, Ulrich M, Rothemeier C, Sachse A . Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity. Nat Microbiol. 2020; 5(7):955-965. DOI: 10.1038/s41564-020-0706-0. View

20.

Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C . Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019; 33(4):1027-1043. PMC: 9533922. DOI: 10.1016/j.idc.2019.03.001. View